In Silico Design of a Chimeric Humanized L-asparaginase.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Apr 2023
Historique:
received: 03 02 2023
revised: 13 04 2023
accepted: 15 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Acute lymphoblastic leukemia (ALL) is the most common cancer among children worldwide, characterized by an overproduction of undifferentiated lymphoblasts in the bone marrow. The treatment of choice for this disease is the enzyme L-asparaginase (ASNase) from bacterial sources. ASNase hydrolyzes circulating L-asparagine in plasma, leading to starvation of leukemic cells. The ASNase formulations of

Identifiants

pubmed: 37108713
pii: ijms24087550
doi: 10.3390/ijms24087550
pmc: PMC10144303
pii:
doi:

Substances chimiques

Asparaginase EC 3.5.1.1
Asparagine 7006-34-0
Recombinant Fusion Proteins 0
Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : São Paulo Research Foundation
ID : 2016/22065-5

Références

Eur J Immunol. 2005 Feb;35(2):505-14
pubmed: 15627976
J Biol Chem. 2014 Nov 28;289(48):33175-86
pubmed: 25320094
BMC Cancer. 2016 Feb 11;16:89
pubmed: 26867931
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
J Hematol Oncol. 2017 Jul 27;10(1):144
pubmed: 28750681
Sci Rep. 2017 Aug 31;7(1):10224
pubmed: 28860480
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W407-10
pubmed: 17517781
Front Immunol. 2016 Feb 02;7:21
pubmed: 26870037
Transplant Rev. 1975;23:78-97
pubmed: 1094633
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1474-8
pubmed: 8434007
Int J Hematol Oncol. 2016 May;5(1):11-25
pubmed: 30302200
J Comput Aided Mol Des. 2008 Mar-Apr;22(3-4):213-28
pubmed: 18196462
Enzyme Microb Technol. 1995 Aug;17(8):757-64
pubmed: 7646879
Crit Rev Oncol Hematol. 2007 Mar;61(3):208-21
pubmed: 17011787
World J Microbiol Biotechnol. 2019 Sep 24;35(10):152
pubmed: 31552479
Methods Mol Biol. 2013;988:31-43
pubmed: 23475712
Cancer. 2011 Jan 15;117(2):238-49
pubmed: 20824725
Comp Biochem Physiol A Mol Integr Physiol. 2020 Mar;241:110634
pubmed: 31841710
Monatsschr Kinderheilkd. 1987 Jun;135(6):325-8
pubmed: 3475571
Leukemia. 2010 Feb;24(2):345-54
pubmed: 20010622
Hum Vaccin Immunother. 2014;10(12):3570-5
pubmed: 25483703
J Clin Invest. 1971 May;50(5):1080-90
pubmed: 4101590
Br J Haematol. 2020 May;189(3):442-451
pubmed: 31883112
Anal Biochem. 2000 Jan 15;277(2):167-76
pubmed: 10625503
BioDrugs. 1997 Jan;7(1):30-9
pubmed: 18031078
Biochim Biophys Acta Gen Subj. 2020 Aug;1864(8):129615
pubmed: 32298791
Nat Rev Drug Discov. 2008 Jan;7(1):21-39
pubmed: 18097458
Cancer. 1982 Apr 1;49(7):1378-83
pubmed: 7037164
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Int J Nanomedicine. 2006;1(3):241-54
pubmed: 17717965
J Biol Chem. 2014 Feb 7;289(6):3555-70
pubmed: 24297177
Metabolites. 2021 Jun 19;11(6):
pubmed: 34205460
J Immunol. 2005 Sep 15;175(6):3603-13
pubmed: 16148104
BMC Bioinformatics. 2014;15 Suppl 4:S1
pubmed: 25104221
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Biophys Chem. 2021 Apr;271:106554
pubmed: 33607531
Clin J Oncol Nurs. 2014 Dec;18(6):E107-12
pubmed: 25427712
Clin Pharmacol Drug Dev. 2021 Dec;10(12):1503-1513
pubmed: 34310867
J Clin Oncol. 2015 Sep 20;33(27):2938-48
pubmed: 26304874
J Anim Sci Technol. 2015 Dec 15;57:44
pubmed: 26672478
Curr Protein Pept Sci. 2019;20(5):452-464
pubmed: 30426897
Blood Rev. 2017 Sep;31(5):328-338
pubmed: 28697948
Biologicals. 2019 May;59:47-55
pubmed: 30871932
Immunogenetics. 2015 Nov;67(11-12):641-50
pubmed: 26416257
Pharmaceutics. 2022 Mar 09;14(3):
pubmed: 35335974
Biomed Pharmacother. 2021 Jul;139:111616
pubmed: 33932739
Cancer Chemother Pharmacol. 2018 Feb;81(2):305-314
pubmed: 29204688
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Biochem J. 1994 Sep 15;302 ( Pt 3):921-7
pubmed: 7945221
Curr Protoc Bioinformatics. 2014 Dec 12;48:3.13.1-3.13.16
pubmed: 25501942
Prep Biochem Biotechnol. 2019;49(7):679-685
pubmed: 30990115
Biotechnol Bioeng. 2014 Nov;111(11):2170-82
pubmed: 24888712
Crit Rev Oncol Hematol. 1998 Aug;28(2):97-113
pubmed: 9768345
Blood. 2011 Feb 3;117(5):1614-21
pubmed: 21106986
Blood. 2014 Aug 21;124(8):1266-76
pubmed: 24970932
Nat Rev Mol Cell Biol. 2022 Jul;23(7):445-446
pubmed: 35477993
J Mol Model. 2014 Jun;20(6):2278
pubmed: 24878803
J Mol Biol. 2014 Jun 26;426(13):2471-85
pubmed: 24768817
Appl Biochem Biotechnol. 2016 Mar;178(5):900-23
pubmed: 26547852
Future Oncol. 2022 Mar;18(10):1285-1299
pubmed: 35107320
Vet World. 2019 Dec;12(12):2036-2045
pubmed: 32095057
Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9
pubmed: 21062830
Pediatr Blood Cancer. 2011 Oct;57(4):569-77
pubmed: 21360654
Zh Mikrobiol Epidemiol Immunobiol. 2014 Nov-Dec;(6):100-4
pubmed: 25816523
Pediatr Blood Cancer. 2010 Feb;54(2):199-205
pubmed: 19672973
J Pediatr Oncol Nurs. 1995 Jan;12(1):46-8
pubmed: 7893462
Protein Pept Lett. 2006;13(2):149-54
pubmed: 16472077
Nucleic Acids Res. 2015 Jul 1;43(W1):W443-7
pubmed: 25873628
PLoS One. 2017 May 24;12(5):e0178174
pubmed: 28542249

Auteurs

Alejandro Pedroso (A)

Department of Chemical Engineering, Faculty of Engineering and Science, Universidad de La Frontera, Temuco 4811230, Chile.

Lisandra Herrera Belén (L)

Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomas, Avenida Carlos Schorr 255, Talca 3460000, Chile.

Jorge F Beltrán (JF)

Department of Chemical Engineering, Faculty of Engineering and Science, Universidad de La Frontera, Temuco 4811230, Chile.

Rodrigo L Castillo (RL)

Department of Internal Medicine, East Division, Faculty of Medicine, University of Chile, Santiago 7500922, Chile.

Adalberto Pessoa (A)

Department of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.

Enrique Pedroso (E)

Department of Family Medicine, Faculty of Medicine, University of Medical Sciences Matanzas, Matanzas 42300, Cuba.

Jorge G Farías (JG)

Department of Chemical Engineering, Faculty of Engineering and Science, Universidad de La Frontera, Temuco 4811230, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH